UBS Group
SLXP

UBS Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

UBS Group’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-66,800
Closed -$11.5M – 9299
2015
Q1 		$11.5M Sell
66,800
-89,100
-57% -$13.1M 0.01% 1359
2014
Q4 		$17.9M Buy
+155,900
New +$18.9M 0.01% 1073

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

UBS Group's SLXP Position: Q2 2015 in Review

UBS Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 45,952 shares — an estimated $7.94M sold.

UBS Group first reported a position in SLXP in Q4 2014 and held it in 2 quarters. The position peaked at $79.5M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • UBS Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • UBS Group sold 45,952 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $7.94M.
  • UBS Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2014 and held it in 2 quarters.
  • UBS Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $79.5M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on UBS Group's 13F filing for Q2 2015, filed 14 Aug 2015.